Retracted: Building on a Strong Foundation to Address a New Era to Help Protect Against Pneumococcal Disease

Chairperson:

Antoni Torres ¹

Speakers:

Mário Ramirez , ^2,3 Charles Feldman , ⁴ Wendy Watson ⁵

1. Respiratory Intensive Care Unit, Department of Pneumology and Respiratory Allergy, Hospital Clinic of Barcelona, University of Barcelona, Spain
2. Faculty of Medicine, University of Lisbon, Portugal
3. Molecular Microbiology and Infection Laboratory, Institute of Molecular Medicine, University of Lisbon, Portugal
4. Department of Internal Medicine, University of the Witwatersrand, Johannesburg, South Africa
5. Vaccines Clinical Research, Pfizer, Collegeville, USA

Acknowledgements:

Writing assistance was provided by International Meetings & Science (IMsci), Stamford, Connecticut, USA.

Citation:

EMJ Microbiol Infect Dis. 2022;3[Suppl 1] https://doi.org/10.33590/emjmicrobiolinfectdis/IWYH8343.

Support:

The symposium and publication of this article were funded by Pfizer, Inc. The views and opinions expressed are exclusively those of the speakers.

Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.